Back to results
US 11,597,732 B2Granted
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
AssigneeCuris, Inc.
InventorsXiong Cai, Haixiao Zhai, Chengjung Lai, Changgeng Qian
Life of this patent
Estimating the term…
Abstract
The instant application relates to deazapurines, thienopyrimidines and furopyrimidines with zinc-binding moiety based derivatives and their use in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.
Claims6
A compound selected from the group consisting of
Dependencies are inferred from the claim text.